Logo

PGxHealth

Nov 12, 2008
Premium
PGxHealth, a division of Clinical Data, announced this week the launch of its new genetic test for arrhythmogenic right ventricular cardiomyopathy, an inherited and often fatal heart condition.
 
The ARVC test is based on Clinical Data’s Familion brand of tests.
 
In 2006 joint guidelines, the American College of Cardiology, American Heart Association, and the European Society of Cardiology supported genetic testing for patients and family members suspected of carrying mutations linked to ARVC. According to Clinical Data, the Familion ARVC Test sequences the five genes most commonly associated with ARVC.

Filed under

Diagnostics
Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.